Andrew Silverman

NephCure Kidney International, Inc. engages in the development of cure for focal segmental glomerulosclerosis and nephrotic syndrome. It also provides education and support that will improve the lives of patients affected by protein-spilling kidney diseases. The company is headquartered in Montgomery, PA.

NephCure Kidney International, Inc. engages in the development of cure for focal segmental glomerulosclerosis and nephrotic syndrome. It also provides education and support that will improve the lives of patients affected by protein-spilling kidney diseases. The company is headquartered in Montgomery, PA.

NephCure Kidney International, Inc. engages in the development of cure for focal segmental glomerulosclerosis and nephrotic syndrome. It also provides education and support that will improve the lives of patients affected by protein-spilling kidney diseases. The company is headquartered in Montgomery, PA.

NephCure Kidney International, Inc. engages in the development of cure for focal segmental glomerulosclerosis and nephrotic syndrome. It also provides education and support that will improve the lives of patients affected by protein-spilling kidney diseases. The company is headquartered in Montgomery, PA.

NephCure Kidney International, Inc. engages in the development of cure for focal segmental glomerulosclerosis and nephrotic syndrome. It also provides education and support that will improve the lives of patients affected by protein-spilling kidney diseases. The company is headquartered in Montgomery, PA.

NephCure Kidney International, Inc. engages in the development of cure for focal segmental glomerulosclerosis and nephrotic syndrome. It also provides education and support that will improve the lives of patients affected by protein-spilling kidney diseases. The company is headquartered in Montgomery, PA.

NephCure Kidney International, Inc. engages in the development of cure for focal segmental glomerulosclerosis and nephrotic syndrome. It also provides education and support that will improve the lives of patients affected by protein-spilling kidney diseases. The company is headquartered in Montgomery, PA.

NephCure Kidney International, Inc. engages in the development of cure for focal segmental glomerulosclerosis and nephrotic syndrome. It also provides education and support that will improve the lives of patients affected by protein-spilling kidney diseases. The company is headquartered in Montgomery, PA.

NephCure Kidney International, Inc. engages in the development of cure for focal segmental glomerulosclerosis and nephrotic syndrome. It also provides education and support that will improve the lives of patients affected by protein-spilling kidney diseases. The company is headquartered in Montgomery, PA.

NephCure Kidney International, Inc. engages in the development of cure for focal segmental glomerulosclerosis and nephrotic syndrome. It also provides education and support that will improve the lives of patients affected by protein-spilling kidney diseases. The company is headquartered in Montgomery, PA.

NephCure Kidney International, Inc. engages in the development of cure for focal segmental glomerulosclerosis and nephrotic syndrome. It also provides education and support that will improve the lives of patients affected by protein-spilling kidney diseases. The company is headquartered in Montgomery, PA.

NephCure Kidney International, Inc. engages in the development of cure for focal segmental glomerulosclerosis and nephrotic syndrome. It also provides education and support that will improve the lives of patients affected by protein-spilling kidney diseases. The company is headquartered in Montgomery, PA.

NephCure Kidney International, Inc. engages in the development of cure for focal segmental glomerulosclerosis and nephrotic syndrome. It also provides education and support that will improve the lives of patients affected by protein-spilling kidney diseases. The company is headquartered in Montgomery, PA.

NephCure Kidney International, Inc. engages in the development of cure for focal segmental glomerulosclerosis and nephrotic syndrome. It also provides education and support that will improve the lives of patients affected by protein-spilling kidney diseases. The company is headquartered in Montgomery, PA.

NephCure Kidney International, Inc. engages in the development of cure for focal segmental glomerulosclerosis and nephrotic syndrome. It also provides education and support that will improve the lives of patients affected by protein-spilling kidney diseases. The company is headquartered in Montgomery, PA.

NephCure Kidney International, Inc. engages in the development of cure for focal segmental glomerulosclerosis and nephrotic syndrome. It also provides education and support that will improve the lives of patients affected by protein-spilling kidney diseases. The company is headquartered in Montgomery, PA.

NephCure Kidney International, Inc. engages in the development of cure for focal segmental glomerulosclerosis and nephrotic syndrome. It also provides education and support that will improve the lives of patients affected by protein-spilling kidney diseases. The company is headquartered in Montgomery, PA.

NephCure Kidney International, Inc. engages in the development of cure for focal segmental glomerulosclerosis and nephrotic syndrome. It also provides education and support that will improve the lives of patients affected by protein-spilling kidney diseases. The company is headquartered in Montgomery, PA.

NephCure Kidney International, Inc. engages in the development of cure for focal segmental glomerulosclerosis and nephrotic syndrome. It also provides education and support that will improve the lives of patients affected by protein-spilling kidney diseases. The company is headquartered in Montgomery, PA.

NephCure Kidney International, Inc. engages in the development of cure for focal segmental glomerulosclerosis and nephrotic syndrome. It also provides education and support that will improve the lives of patients affected by protein-spilling kidney diseases. The company is headquartered in Montgomery, PA.

NephCure Kidney International, Inc. engages in the development of cure for focal segmental glomerulosclerosis and nephrotic syndrome. It also provides education and support that will improve the lives of patients affected by protein-spilling kidney diseases. The company is headquartered in Montgomery, PA.

NephCure Kidney International, Inc. engages in the development of cure for focal segmental glomerulosclerosis and nephrotic syndrome. It also provides education and support that will improve the lives of patients affected by protein-spilling kidney diseases. The company is headquartered in Montgomery, PA.

NephCure Kidney International, Inc. engages in the development of cure for focal segmental glomerulosclerosis and nephrotic syndrome. It also provides education and support that will improve the lives of patients affected by protein-spilling kidney diseases. The company is headquartered in Montgomery, PA.

NephCure Kidney International, Inc. engages in the development of cure for focal segmental glomerulosclerosis and nephrotic syndrome. It also provides education and support that will improve the lives of patients affected by protein-spilling kidney diseases. The company is headquartered in Montgomery, PA.

NephCure Kidney International, Inc. engages in the development of cure for focal segmental glomerulosclerosis and nephrotic syndrome. It also provides education and support that will improve the lives of patients affected by protein-spilling kidney diseases. The company is headquartered in Montgomery, PA.